In Situ Immunocytological and Molecular Pathological Analysis of the Lesions in the Target Organs of Chronic GvH Disease
慢性GvH病靶器官病变的原位免疫细胞学和分子病理学分析
基本信息
- 批准号:06670225
- 负责人:
- 金额:$ 1.41万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1994
- 资助国家:日本
- 起止时间:1994 至 1995
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Following results were obtained using mouse models of chronic GvHR and GvHD.1.Chronic GvHR was induced by inoculating parental lymphoid cells into F1 hybrid mouse. Combination of ATL and ATH,which were congenic recombinant strains differing only in H-2I and S region from each other, was chosen to induce class II-GvHR.Selective activation against partner's alloantigen of graft CD4^+ T cells was the primary event of the GvHR and then led to concomitant activation of both graft and host cells. In particular combinations of strains differing whole MHC antigens, namely, DBA/2* (C57BL/6xDBA/2) F1 or BALB/c* (BALB/cxA/J) F1, preferential but not selective activation of graft CD4^+ cells was characteristically observed. Contributing factors to this phenomenon were low responsiveness of graft CD8^+ T cells to allogeneic class I MHC antigens and anti-DBA/2 activity of host CD8 cells in the case of D2-GvHR.Predominant activation of CD4 cells in the chronic GvH-spleen was expressed as the ratio of CD4/CD8 was always >1.2.Moderate atrophy of the thymus was observed in the 2nd week of GvHR.Increase of the frequency of apoptotic cell and decrease of S phase cell were cellular event leading to its atrophy. Although it was not so obvious as acute GvHR,cellular change occurred as early process of atrophy was essentially same between chronic and acute GvHR's.3.Non-suppurative destructive cholangitis was a liver lesion of chronic GvH disease. It was characterized by periductal and intraepithelial infiltration of lymphocyte in the portal area and strong expression of MHC class II antigen on the epithelial membrane as early as 2nd day of GvHR.Interferon-gamma produced in site was important factor to induce aberrant expression of the antigen.
慢性GvHR和gvhd小鼠模型得到如下结果:用亲代淋巴样细胞接种F1杂交小鼠诱导慢性GvHR。选择仅H-2I区和S区不同的同源重组菌株ATL和ATH联合诱导ii类gvhr。移植物CD4^+ T细胞对伴侣异体抗原的选择性激活是GvHR的主要事件,然后导致移植物和宿主细胞的伴随激活。特别是在不同MHC抗原的菌株组合中,即DBA/2* (C57BL/6xDBA/2) F1或BALB/c* (BALB/cxA/J) F1,特异性地观察到移植物CD4^+细胞的优先而非选择性活化。导致这一现象的因素是移植物CD8^+ T细胞对同种异体I类MHC抗原的低反应性和宿主CD8细胞在D2-GvHR情况下的抗dba /2活性。慢性gvh -脾中以CD4细胞活化为主,CD4/CD8比值始终为bb0 1.2。GvHR第2周胸腺出现中度萎缩。凋亡细胞频率增加,S期细胞减少是导致其萎缩的细胞事件。虽然不像急性GvHR那么明显,但由于慢性和急性GvHR的早期萎缩过程基本相同,发生了细胞改变。非化脓性破坏性胆管炎是慢性GvH病的一种肝脏病变。其特点是早在GvHR第2天,门管区淋巴细胞和上皮内浸润,上皮膜上强烈表达MHC II类抗原。现场产生的干扰素γ是诱发抗原异常表达的重要因素。
项目成果
期刊论文数量(30)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
原田,孝之: "移植の合併性-GvHD" 病理と臨床. 11. 443-450 (1993)
Harada, Takayuki:“移植并发症 - GvHD”病理学和临床研究 11. 443-450 (1993)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Harada, T.: "Progress in Bone Marrow Transplantation." Shimane Journal of Medicine (Shimane Igaku in Japanese). 16. 11-19 (1996)
Harada, T.:“骨髓移植的进展。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
原田,孝之: "骨髄移植" 臨床免疫学,狩野他編集,朝倉書店. 印刷中. (1996)
Harada, Takayuki:“骨髓移植”临床免疫学,由 Kano 等编辑,Asakura Shoten 出版(1996 年)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Harada, T.: "Complications in transplantation-GvHD." Pathology and Clinic (Byori to Rinsho, in Japanese). 11. 443-450 (1993)
Harada, T.:“移植并发症 - GvHD。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
原田 孝之: "骨髄移植とその発展" 島根医学. 16. 11-19 (1996)
原田贵之:“骨髓移植及其发展”岛根医学16. 11-19 (1996)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HARADA Takayuki其他文献
HARADA Takayuki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HARADA Takayuki', 18)}}的其他基金
Layered metallic material/semiconductor heterostructures for harsh-environment electronics
用于恶劣环境电子产品的层状金属材料/半导体异质结构
- 批准号:
20H02611 - 财政年份:2020
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Establishment of animal models of neurodegenerative diseases and development of therapeutic strategies utilizing optogenetics
神经退行性疾病动物模型的建立及光遗传学治疗策略的开发
- 批准号:
18K19625 - 财政年份:2018
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Generation of a marmoset model of normal tension glaucoma and investigation into neuroprotection and neuroregeneration for glaucoma therapy
正常眼压青光眼狨猴模型的建立及青光眼治疗的神经保护和神经再生研究
- 批准号:
15H04999 - 财政年份:2015
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Functional analyses of the role of oncomodulin in axon regeneration
癌调节蛋白在轴突再生中作用的功能分析
- 批准号:
26640048 - 财政年份:2014
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
The development of community-based treatment program for substance use disorder
药物滥用障碍社区治疗计划的制定
- 批准号:
26380947 - 财政年份:2014
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The development of a coping skills training program for craving control of methamphetamine users
制定应对技巧培训计划以控制甲基苯丙胺使用者的渴望
- 批准号:
22530754 - 财政年份:2010
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidation of the pathogenesis of normal tension glaucoma and the development of its treatment by neuroprotection and axon regeneration
阐明正常眼压性青光眼的发病机制以及神经保护和轴突再生治疗的进展
- 批准号:
19390447 - 财政年份:2007
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Expression of Inositol, 1,4,5-trisphosphate Receptor in the Nucleus of Human Benign and Malignant Squamous Cells and Its Significance
肌醇、1,4,5-三磷酸受体在人良恶性鳞状细胞核中的表达及其意义
- 批准号:
07671858 - 财政年份:1995
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
外泌体ORM1作为肿瘤免疫微环境中T细胞耗竭(T Cell Exhaustion)生物标志物及其功能研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Understanding T cell trafficking and function during antigenic interference
了解抗原干扰期间 T 细胞的运输和功能
- 批准号:
DP240101665 - 财政年份:2024
- 资助金额:
$ 1.41万 - 项目类别:
Discovery Projects
Hedgehog signalling in T-cell differentiation and function
T 细胞分化和功能中的 Hedgehog 信号传导
- 批准号:
BB/Y003454/1 - 财政年份:2024
- 资助金额:
$ 1.41万 - 项目类别:
Research Grant
I-Corps: Chimeric Antigen Receptor T Cell Manufacturing for Cancer Therapies
I-Corps:用于癌症治疗的嵌合抗原受体 T 细胞制造
- 批准号:
2403974 - 财政年份:2024
- 资助金额:
$ 1.41万 - 项目类别:
Standard Grant
Defining pathways that control T cell lifespan for long-term immunity
定义控制 T 细胞寿命的途径以实现长期免疫
- 批准号:
DP240102812 - 财政年份:2024
- 资助金额:
$ 1.41万 - 项目类别:
Discovery Projects
Evaluating gamma-delta T cell therapy for osteosarcoma
评估骨肉瘤的 γ-δ T 细胞疗法
- 批准号:
MR/X033066/1 - 财政年份:2024
- 资助金额:
$ 1.41万 - 项目类别:
Fellowship
Designing Rational Combinations to Improve CAR T Cell Therapy for Prostate Cancer
设计合理的组合以改善前列腺癌的 CAR T 细胞疗法
- 批准号:
10752046 - 财政年份:2024
- 资助金额:
$ 1.41万 - 项目类别:
The molecular basis of T cell receptor cross-reactivity between MHC and MR1
MHC 和 MR1 之间 T 细胞受体交叉反应的分子基础
- 批准号:
DP240102905 - 财政年份:2024
- 资助金额:
$ 1.41万 - 项目类别:
Discovery Projects
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
- 批准号:
23K28188 - 财政年份:2024
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Systematically defining the T cell signalling network of the phosphatase CD45
系统定义磷酸酶 CD45 的 T 细胞信号网络
- 批准号:
BB/Y000587/1 - 财政年份:2024
- 资助金额:
$ 1.41万 - 项目类别:
Research Grant
Optimisation of small molecule inhibitors for effective targeting of phospholipase C gamma in T-cell lymphoma
优化小分子抑制剂以有效靶向 T 细胞淋巴瘤中的磷脂酶 C γ
- 批准号:
MR/Y503344/1 - 财政年份:2024
- 资助金额:
$ 1.41万 - 项目类别:
Research Grant














{{item.name}}会员




